Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery …
Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery …
CAMBRIDGE, Mass., Jan. 20, 2011 /PRNewswire/ — Pervasis Therapeutics, Inc. today announced it will present interim data from the company’s Phase 1/2 clinical study of PVS-10200, an investigational cell-based therapy under development to prevent restenosis in patients with [...]